CClinicalTrials.gg
CompletedNCT03602170Updated Apr 26, 2019

Cardiovascular Effects of High-Intensity Interval Training (HIIT)

An interventional study of High-Intensity Interval Training and Moderate-Intensity Continuous Training in Healthy Sedentary Adults With BP <140/90, sponsored by University of Delaware. Completed at 1 site in United States. Open to participants aged 20 Years to 44 Years. Per ClinicalTrials.gov, last updated 2019-04-26.

Sponsored by University of Delaware · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Mar 2017, registered Jun 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 44 Years
Sex
All
01

Study summary

The purpose of this study is to determine the effect of high-intensity interval training (HIIT) in comparison to moderate-intensity continuous training (MCT) on blood pressure, blood vessel function, and blood pressure reactivity.

Read the detailed description

It is estimated that one-third of the adult population in the United States has blood pressure values that are classified as prehypertension. This slight elevation in blood pressure has been shown to result in an increased risk for developing hypertension and cardiovascular disease. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) recommends lifestyle modifications for individuals classified as prehypertensive. One lifestyle modification suggested by JNC7 is regular physical activity. Aerobic exercise, like moderate-intensity continuous training (MCT), has been shown to improve blood pressure, blood vessel function, and arterial stiffness in those with prehypertension. However, a major barrier to exercise adherence is the time commitment required. High-Intensity Interval Training (HIIT), which requires individuals to work at higher intensities for shorter durations, may offer an alternative training design that would reduce the time commitment. Previous studies have shown HIIT to be equal to or better at improving cardiorespiratory fitness and blood vessel function in multiple populations. Limited information is present on HIIT training in those with prehypertension. In this study, participants will be randomized into one of the two training program designs mentioned above (MCT or HIIT). Both programs will be completed over an 8-week period (3 sessions per week) and each training session will be supervised. Participants will complete testing visits before and after the training program to collect measures of cardiovascular health (exercise capacity, blood pressure, blood vessel function, and blood pressure reactivity). The goal is to compare the effects of the training programs on these measures of cardiovascular health.

02

Conditions studied

  • Healthy Sedentary Adults With BP <140/90

Keywords

  • High-Intensity Interval Training
  • Exercise
  • Cardiovascular Health
  • Blood Pressure
03

In context

Lead sponsor

University of Delaware is the lead sponsor of 125 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 44 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Blood Pressure less than 140/90 mmHg
  • Sedentary

Exclusion criteria

Exclusion Criteria:

  • Known or major signs/symptoms of cardiovascular, pulmonary, renal, or metabolic disease
  • Cancer
  • Use of antihypertensive medication
  • Current tobacco use
  • BMI (body mass index) less than 30 kg/m2
  • Postmenopausal
  • Current pregnancy
  • Current hormone replacement therapy
  • Participating in regular aerobic exercise at least three times a week for 30 minutes at a moderate intensity for the past 3 months or more
  • Not able to regularly exercise for any reason
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    High-Intensity Interval Training

    8 weeks of high-intensity interval training. Three sessions per week will be performed (24 total sessions).

    Behavioral: High-Intensity Interval Training

  • Active comparator
    Moderate-Intensity Continuous Training

    8 weeks of moderate-intensity continuous training. Three sessions per week will be performed (24 total sessions).

    Behavioral: Moderate-Intensity Continuous Training

Interventions

  • BehavioralHigh-Intensity Interval Training

    Supervised exercise sessions will be performed on a upright cycle ergometer. Training sessions involve 20 minutes of exercise by completing 10 repetitions of 60 seconds of exercise at 90-95% maximal heart rate with 60 seconds of active rest between each repetition at 50-60% maximal heart rate.

  • BehavioralModerate-Intensity Continuous Training

    Supervised exercise sessions will be performed on a upright cycle ergometer. Training sessions involve 30 minutes of continuous exercise at 65-70% maximal heart rate.

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Resting blood pressures measuring by automated oscillometric device

    Time frame: Change from baseline resting blood pressure at 8 weeks

Secondary outcomes

  1. Peak Aerobic Capacity

    Peak oxygen uptake (VO2peak/max) during incremental cycling exercise until exhaustion

    Time frame: Change from baseline VO2peak at 8 weeks

  2. 24-Hour Ambulatory Blood Pressure

    24 hours of continuous ambulatory blood pressure monitoring by oscillometric device

    Time frame: Change from baseline 24-hour ambulatory blood pressure at 8 weeks

  3. Pulse Wave Analysis

    Central blood pressure measures assessed by radial tonometry

    Time frame: Change from baseline central blood pressure measures at 8 weeks

  4. Endothelial Function

    Assessed by brachial artery flow mediated dilation and change in blood in femoral artery in response to passive limb movement

    Time frame: Change from baseline endothelial function at 8 weeks

  5. Arterial stiffness

    Pulse wave velocity measures (carotid to femoral and femoral to distal) assessed by applanation tonometry

    Time frame: Change from baseline pulse wave velocity measures at 8 weeks

  6. Blood Pressure Reactivity

    Blood pressure response to graded exercise test and handgrip exercise

    Time frame: Change from baseline blood pressure reactivity at 8 weeks

Other outcomes

  1. Perceived Enjoyment of Exercise

    Enjoyment rating based on 18-item questionnaire

    Time frame: Measured after 4 and 8 weeks of training

07

Study locations

1 site
  • Department of Kinesiology and Applied Physiology, University of Delaware
    Newark, Delaware 19713, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03602170
Lead sponsor
University of Delaware
Responsible party
David Edwards (Professor, University of Delaware) — Principal investigator
First posted
Jul 26, 2018
Start date
Mar 30, 2017
Primary completion
Nov 6, 2018
Completion
Nov 6, 2018
Last update
Apr 26, 2019

Study contacts

Bryce J Muth, MS
principal investigator · University of Delaware
David G Edwards, PhD
principal investigator · University of Delaware

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion